Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

Autor: Lin, Yi *, Qiu, Lugui, Usmani, Saad, Joo, Chng Wee, Costa, Luciano, Derman, Benjamin, Du, Juan, Einsele, Hermann, Fernandez de Larrea, Carlos, Hajek, Roman, Ho, P Joy, Kastritis, Efstathios, Martinez-Lopez, Joaquin, Mateos, Maria-Victoria, Mikhael, Joseph, Moreau, Philippe, Nagarajan, Chandramouli, Nooka, Ajay, O'Dwyer, Michael, Schjesvold, Fredrik, Sidana, Surbhi, van de Donk, Niels WCJ, Weisel, Katja, Zweegman, Sonja, Raje, Noopur, Otero, Paula Rodriguez, Anderson, Larry D, Jr, Kumar, Shaji, Martin, Tom
Zdroj: In The Lancet Oncology August 2024 25(8):e374-e387
Databáze: ScienceDirect